Web Stats Provided By Google Analytics

The Raw Stem Cell News Feed

The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research

Thursday, November 13, 2014

Biotech Stock Mailbag: Spectrum, Intercept, Orexigen, Amarin, MannKind

Mike's apparently having a bad day at the races, but I'll try to rise above it and answer his question. First the basics on this one: Spectrum licensed Captisol-enabled melphalan from Ligand Pharmaceuticals .

http://ift.tt/1tO1OXT
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Popular Stem Cell Roundup Posts